In Brief: Astra Merck Prilosec
This article was originally published in The Tan Sheet
Executive Summary
Astra Merck Prilosec: Astra plans to file applications for effervescent formulation of the proton pump inhibitor omeprazole in European markets during the first quarter of 1999. Astra Merck maintains it has not yet determined plans for the effervescent formulation, nor has it selected an OTC dosage form. The effervescent tablet would be a logical option for the company to pursue in an OTC switch. The Jan. 26 issue of "The Tan Sheet" (p. 1) had reported the filing would be in the U.S...